|
|
|
|
|
|
Dynavax Technologies (DVAX)
|
|
5.55 0 (+0.00%)
|
5/25/2017 4:00pm
|
|
Open:
|
5.60
|
Pre. Close:
|
5.55
|
|
High:
|
5.60
|
Low:
|
5.50
|
|
Volume:
|
194,982
|
Market Cap:
|
270.80M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
5.69 - 5.76
|
5.76 - 5.88
|
|
Low:
|
5.24 - 5.33
|
5.33 - 5.46
|
|
Close:
|
5.4 - 5.52
|
5.52 - 5.71
|
|
|
|
|
|
|
Technical analysis (as of: 2017-05-25 4:40:19 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 6.95 One year: 8.12
|
|
Support:
|
Support1: 5.46 Support2: 5.15
|
|
Resistance:
|
Resistance1:
5.95 Resistance2: 6.95
|
|
Pivot:
|
5.55 
|
|
Moving Averages:
|
MA(5): 5.54  MA(20): 5.54
MA(100): 5.08 MA(250): 8.95
|
|
MACD:
|
MACD(12,26):
Signal(12,26,9):
|
|
%K %D:
|
%K(14,3): 69.44 %D(3): 66.67
|
|
RSI:
|
RSI(14): 49.59
|
|
52-Week:
|
High: 17.50
Low: 3.20 Change(%): -65.0
|
|
Average Vol(K):
|
3-Month: 95505
10-Days 31548
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.DVAX has closed above bottom band by 50.0%. Bollinger Bands are 78.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to DVAX's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Wed, 01 Mar 2017 14:37:11 GMT
Why Dynavax Technologies Corporation Stock Is Skyrocketing Today
Fri, 03 Mar 2017 13:18:45 GMT
Dynavax: A Wee Glimmer Of Hope
Wed, 18 Jan 2017 19:52:15 GMT
Dynavax In 2017: Hero Or Zero?
Wed, 05 Apr 2017 15:56:15 GMT
Dynavax: Important Catalyst For SD101
Tue, 17 Jan 2017 20:01:43 GMT
Dynavax Technologies: Valuation Of The Immune-Oncology Pipeline
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
